Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Option activity in these three fallen angel stocks has ticked up lately, and the shares could be ready to follow along for ...

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

The newly-constructed, two-story building was designed to enhance patient comfort and convenience and enhance provider ...

WOONSOCKET, R.I., Jan. 28, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS ) today announced the launch of the CVS Health app. New features of the app will bring together all CVS Health has to offer to ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers ... and marking up the prices of specialty drugs. The report specifically looked ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

Out of tens of thousands of drugs dispensed, the top 10 specialty generics alone made up nearly 11% of the companies’ pharmacy-related operating income that year, the agency estimated.